查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654304

全球猪隻疫苗市场：市场规模、份额、趋势分析（按产品、类型、给药途径和地区）、细分市场预测（2025-2030 年）

Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Modified/Attenuated Live), By Type (Pseudorabies, Porcine Circovirus Type 2), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

猪疫苗市场的成长与趋势：

根据 Grand View Research 的新报告，到 2030 年全球猪隻疫苗市场规模预计将达到 24.1 亿美元。

预计 2025 年至 2030 年期间该市场的复合年增长率为 5.51%。猪隻病患病率和发病率的不断上升、人们对通用感染疾病的日益担忧以及养猪场生物安全措施的加强是推动市场成长的一些主要因素。此外，政府和兽医组织为传播疾病意识和支持疫苗接种所做的努力将进一步推动预测期内的市场成长。

新冠肺炎疫情对主要企业的猪疫苗业务产生了直接或间接的影响，初期业绩表现不佳。疫情对各类生产和供应链瓶颈的影响，导致必要原料和活性成分供应延迟，部分研发活动延后。然而，近期多地区同时爆发的非洲猪瘟疫情为猪疫苗生产企业带来了庞大的需求。 2020年，世界动物卫生组织通报亚洲共发生9,928例非洲猪瘟病例，其次是欧洲，共报告4,271例。因此，政府考虑到这种情况，透过放鬆管制来支持猪疫苗的分发。

此外，抗生素抗药性已成为全球农业和兽医学领域日益关注的问题。因此，一些国家禁止在畜牧业生产中使用抗生素，包括作为预防和治疗手段。该法强制要求养猪场采用无抗生素的方法来预防疾病，例如接种疫苗。此外，主要企业不断增加对开髮用于更好诊断的先进产品的投资可能会促进市场的发展。例如，2020 年 5 月，印度免疫学有限公司 (Indian Immunologicals Ltd.) 推出了一种以「Raksha Class」为品牌的猪瘟疫苗，该疫苗基于与印度巴雷利兽医研究所合作开发的专有细胞培养技术。

市场的主要企业正在采取各种策略性倡议，企业合併、合作、产品发布等，以保持市场竞争力。例如，2022年3月，Ceva推出了母猪疫苗，这是一款含有七种抗原的疫苗，用于治疗新生儿腹泻。

猪疫苗市场：分析概述

  • 灭活疫苗占市场主导地位，2024 年销售额份额最大，为 52.03%。这是因为它们比活病毒疫苗具有易于取得、成本低和稳定等优势。
  • 根据疾病类型，PRRS（猪生殖与呼吸症候群）在 2024 年占据市场主导地位，收入份额最大，为 14.26%。
  • 根据给药途径，注射剂在 2024 年占据市场最大收益占有率，达到 75.79%，这得益于其在为猪提供针对主要疾病的长期保护方面的效率和效果。
  • 按分销管道划分，医院/诊所药房在 2024 年占据最大的销售份额。这是因为直接的终端使用者参与、即时疫苗接种服务和全面的医疗保健解决方案确保了及时分发疫苗和有效控制畜牧业的疾病。
  • 2024 年北美占据猪隻疫苗市场最大的销售份额，为 38.46%。

目录

第一章 分析方法及范围

第 2 章执行摘要

第三章 猪疫苗市场：驱动因素、趋势与范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 猪疫苗市场：分析工具
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析
    • 政局
    • 产品平臺分析
    • COVID-19 分析
    • 主要国家生猪数量预估（2018-2024）

第 4 章 猪隻疫苗市场：依产品分類的业务分析

  • 按产品市场占有率（2024 年和 2030 年）
  • 产品仪表板
  • 依产品分類的市场规模预测及趋势分析（2018-2030）
  • 修正/阻尼
  • 灭活（杀死）
  • 其他的

第 5 章猪疫苗市场：依疾病类型进行的商业分析

  • 按疾病类型分類的市场占有率（2024 年和 2030 年）
  • 疾病类型仪表板
  • 依疾病类型分類的市场规模预测及趋势分析（2018-2030 年）
  • 猪流感
  • 猪霍乱
  • 猪细小病毒
  • 猪环状病毒2 型
  • M.Hyo
  • 肺炎放线桿菌
  • 抗逆转录病毒药物
  • 口蹄疫
  • 伪狂犬病
  • PEDV

6. 猪隻疫苗市场：依给药途径进行的业务分析

  • 按管理途径分類的市场占有率（2024 年和 2030 年）
  • 管理路线仪表板
  • 依管理途径分類的市场规模预测及趋势分析（2018-2030 年）
  • 注射
  • 鼻腔
  • 口服

第 7 章猪疫苗市场：按通路分類的业务分析

  • 按分销管道分類的市场占有率（2024 年和 2030 年）
  • 分销通路仪表板
  • 按分销管道分類的市场规模预测及趋势分析（2018-2030 年）
  • 零售
  • 电子商务
  • 医院/诊所药房

第 8 章 猪隻疫苗市场：区域估计与趋势分析（依产品、疾病类型、给药途径及通路）

  • 各地区市场占有率（2024 年及 2030 年）
  • 区域市场仪表板
  • 各地区市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非

第九章 竞争格局

  • 参与企业概况
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Merck &Co., Inc.
    • Ceva
    • Zoetis
    • Boehringer Ingelheim GmbH
    • Elanco
    • Indian Immunologicals Ltd.
    • BiogenesisBago
    • Phibro Animal Health
    • KM Biologics
    • HIPRA
    • Virbac

第十章 重点

Product Code: GVR-4-68039-728-0

Swine Vaccines Market Growth & Trends:

The global swine vaccines market size is expected to reach USD 2.41 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness a lucrative CAGR of 5.51% from 2025 to 2030. The increasing prevalence and incidence of swine diseases, rising concerns over zoonoses, and strengthening biosecurity measures among swine farms are some of the major factors augmenting the market growth. In addition, the initiatives taken by government and animal healthcare organizations in spreading disease awareness and supporting vaccination drives are further propelling the market growth during the projected period.

The Covid-19 pandemic has directly or indirectly impacted the key player's swine vaccine business operations and resulted in declined financial performance during the initial time. The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, the simultaneously reported African swine fever outbreaks in several regions pressured the swine vaccine manufacturers with a large demand. In 2020, the OIE reported 9,928 ASF outbreaks in Asia, followed by 4,271 outbreaks in Europe. Hence, considering the situation, the government supported the distribution of swine vaccines with ease of restrictions, which afforded opportunities to rebuild the company's growth.

In addition, the global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Thus, several countries have banned the use of antibiotics for livestock farming, including preventive treatment procedures. This act has compelled swine farms to adopt antibiotic-free disease preventive approaches such as vaccination. Furthermore, growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine under the brand name 'Raksha Class', a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players in the market are implementing various strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, In March 2022, Ceva launched the sow vaccine, a vaccine containing seven antigens used to treat neonatal diarrhea.

Swine Vaccines Market Report Highlights:

  • The Inactivated (Killed) segment led the market with the largest revenue share of 52.03% in 2024. This is attributed to its easy availability, low cost, and stability advantages over live-attenuated vaccines.
  • Based on disease type, the PRRS (Porcine Reproductive and Respiratory Syndrome) led the market with the largest revenue share of 14.26% in 2024.
  • Based on route of administration, the injectable segment led the market with the largest revenue share of 75.79% in 2024, due to its efficiency and effectiveness in providing long-lasting protection against major diseases in pigs.
  • Based on distribution channel, the hospital/clinic pharmacies segment accounted for the largest revenue share in 2024, due to their direct engagement with end-users, immediate vaccination services, and comprehensive healthcare solutions, ensuring timely vaccine distribution and effective disease management in the livestock sector.
  • North America dominated the swine vaccines market with the largest revenue share of 38.46% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease Type
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Swine Vaccines Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising concern about zoonoses & strengthening biosecurity
      • 3.2.1.2. Vaccines act as an alternative to antibiotics
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Supply bans on live pigs and pork products
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Political Landscape
      • 3.3.3.1. Economic Landscape
      • 3.3.3.2. Social Landscape
      • 3.3.3.3. Technology Landscape
      • 3.3.3.4. Legal Landscape
      • 3.3.3.5. Environmental Landscape
      • 3.3.3.6. Regulatory Landscape
    • 3.3.4. Product Pipeline Analysis
    • 3.3.5. Covid-19 Analysis
    • 3.3.6. Estimated Pig population by key countries, 2018 to 2024

Chapter 4. Swine Vaccines Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Modified/Attenuated Live
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Inactivated (Killed)
    • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Swine Vaccines Market: Disease Type Business Analysis

  • 5.1. Disease Type Market Share, 2024 & 2030
  • 5.2. Disease Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2018 to 2030 (USD Million)
  • 5.4. Swine Influenza
    • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Classical Swine Fever
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Porcine Parvovirus
    • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Porcine Circovirus Type 2
    • 5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. M.Hyo
    • 5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Actinobacillus Pleuropneumonia
    • 5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. PRRS
    • 5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.11. Foot & Mouth Disease
    • 5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.12. Pseudorabies
    • 5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.13. PEDV
    • 5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Swine Vaccines Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Injectables
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Intranasal
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Oral
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Swine Vaccines Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2024 & 2030
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 7.4. Retail
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. E-commerce
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Hospital/Clinic Pharmacies
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Swine Vaccines Market: Regional Estimates & Trend Analysis by Product, Disease Type, Route of Administration, and Distribution Channel

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. U.S. swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Canada swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Mexico swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. UK swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Germany swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. France swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Italy swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Spain swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Norway swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Denmark swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Sweden swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Japan swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. China swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. India swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. South Korea swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Australia swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Thailand swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Brazil swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Argentina swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. South Africa swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Merck & Co., Inc.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Ceva
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Zoetis
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Boehringer Ingelheim GmbH
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Elanco
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Indian Immunologicals Ltd.
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. BiogenesisBago
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Phibro Animal Health
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. KM Biologics
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. HIPRA
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Virbac
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives

Chapter 10. Key Takeaways

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 5 Global Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 Global Swine Vaccines Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 11 North America Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 North America Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 U.S. Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 U.S. Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Canada Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 20 Canada Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Mexico Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 23 Mexico Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Mexico Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 Europe Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Europe Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 28 Europe Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 Europe Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 Germany Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 32 Germany Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Germany Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 UK Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 UK Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 36 UK Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 UK Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 France Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 France Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 40 France Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 France Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Italy Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Italy Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 44 Italy Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Italy Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Spain Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 48 Spain Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Spain Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Denmark Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 52 Denmark Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 Denmark Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Sweden Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 56 Sweden Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Sweden Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Norway Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 59 Norway Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 60 Norway Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Norway Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 China Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 China Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 69 China Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 China Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 Japan Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 73 Japan Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 India Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 India Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 77 India Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 India Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 South Korea Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 81 South Korea Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 South Korea Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Australia Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 85 Australia Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 86 Australia Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Thailand Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 89 Thailand Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Thailand Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Latin America Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 Latin America Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 94 Latin America Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 95 Latin America Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 Brazil Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Brazil Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 98 Brazil Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 99 Brazil Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 100 Argentina Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 103 Argentina Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 South Africa Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 112 South Africa Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Swine Vaccines Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Swine Vaccines Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 Global Swine Vaccines Market, for Modified/Attenuated Live, 2018 - 2030 (USD Million)
  • Fig. 16 Global Swine Vaccines Market, for Inactivated (Killed), 2018 - 2030 (USD Million)
  • Fig. 17 Global Swine Vaccines Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 18 Global Swine Vaccines Market, for Disease Type, 2018 - 2030 (USD Million)
  • Fig. 19 Global Swine Vaccines Market, for Swine Influenza, 2018 - 2030 (USD Million)
  • Fig. 20 Global Swine Vaccines Market, for Classical Swine Fever, 2018 - 2030 (USD Million)
  • Fig. 21 Global Swine Vaccines Market, for Porcine Parvovirus, 2018 - 2030 (USD Million)
  • Fig. 22 Global Swine Vaccines Market, for Porcine Circovirus Type 2, 2018 - 2030 (USD Million)
  • Fig. 23 Global Swine Vaccines Market, for M.Hyo, 2018 - 2030 (USD Million)
  • Fig. 24 Global Swine Vaccines Market, for Actinobacillus Pleuropneumonia, 2018 - 2030 (USD Million)
  • Fig. 25 Global Swine Vaccines Market, for PRRS, 2018 - 2030 (USD Million)
  • Fig. 26 Global Swine Vaccines Market, for Foot & Mouth Disease, 2018 - 2030 (USD Million)
  • Fig. 27 Global Swine Vaccines Market, for Pseudorabies, 2018 - 2030 (USD Million)
  • Fig. 28 Global Swine Vaccines Market, for PEDV, 2018 - 2030 (USD Million)
  • Fig. 29 Global Swine Vaccines Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Global Swine Vaccines Market, for Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 31 Global Swine Vaccines Market, for Injectables, 2018 - 2030 (USD Million)
  • Fig. 32 Global Swine Vaccines Market, for Intranasal, 2018 - 2030 (USD Million)
  • Fig. 33 Global Swine Vaccines Market, for Oral, 2018 - 2030 (USD Million)
  • Fig. 34 Global Swine Vaccines Market, for Distribution Channel, 2018 - 2030 (USD Million)
  • Fig. 35 Global Swine Vaccines Market, for Retail, 2018 - 2030 (USD Million)
  • Fig. 36 Global Swine Vaccines Market, for E-Commerce, 2018 - 2030 (USD Million)
  • Fig. 37 Global Swine Vaccines Market, for Hospital/Clinic Pharmacies, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Outlook, 2024 & 2030
  • Fig. 39 North America Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 64 Company categorization
  • Fig. 65 Company market position analysis
  • Fig. 66 Strategic framework